Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness

Clinical trial NCT04870606 · COMPLETED

Trial details

NCT number: NCT04870606
Sponsor: Suzhou Kintor Pharmaceutical Inc,
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Efficacy and Safety

Start date: 2021-03-05
Primary completion: 2022-01-24
Enrollment: 733

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.